Full list of author information is available at the end of the articleBackground P-glycoprotein (Pgp) is a 170 kDa membrane-bound efflux transporter located in several organs throughout the body with an excretory and/or barrier function, such as the liver, kidneys, intestine, placenta, testes and the blood–brain barrier (BBB) [1]. At the BBB, Pgp is highly expressed and has an important function in the transport of a wide variety of endogenous and exogenous substances out of the brain into the blood-stream [2]. Pgp has been shown to play a role in amyloid-beta clearance from the brain and, as such, has been hypothesized to be involved in the pathogenesis of Alzheimer's disease (AD) [3]. Recently, BBB Pgp dys-function in AD patients was...
The accumulation of amyloid-b (Ab) peptides is a key histopathological feature of the Alzheimer's b...
Full list of author information is available at the end of the articleResults: PAPP-A was elevated i...
Amyloid precursor protein (APP) has been modified by β and γ-secretase that cause amy-loid deposits ...
This thesis reveals additional insights in the functional behavior of P-glycoprotein in the human bl...
A major pathological hallmark of Alzheimer’s disease is accumulation of amyloid-b in senile plaques ...
textabstractBackground: P-glycoprotein is a blood-brain barrier efflux transporter involved in the c...
m olpharm.aspetjournals.org D ow nloaded from 2 ATP-binding cassette transporters such as P-glycopro...
P-glycoprotein (P-gp) is an ATP-dependent efflux transporter located at the blood–brain barrier (BB...
Purpose: P-glycoprotein (Pgp) is an efflux transporter involved in transport of several compounds ac...
Abstract: The blood-brain barrier (BBB) impedes the influx of intravascular compounds from the blood...
Background: P-glycoprotein is a blood-brain barrier efflux transporter involved in the clearance of ...
Full list of author information is available at the end of the articleBackground Alzheimer’s disease...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Protection of the brain is strengthened by active transport and ABC transporters. P-glycoprotein (P-...
<p>One characteristic of Alzheimer’s disease (AD) is excessive accumulation of amyloid-β (Aβ) in the...
The accumulation of amyloid-b (Ab) peptides is a key histopathological feature of the Alzheimer's b...
Full list of author information is available at the end of the articleResults: PAPP-A was elevated i...
Amyloid precursor protein (APP) has been modified by β and γ-secretase that cause amy-loid deposits ...
This thesis reveals additional insights in the functional behavior of P-glycoprotein in the human bl...
A major pathological hallmark of Alzheimer’s disease is accumulation of amyloid-b in senile plaques ...
textabstractBackground: P-glycoprotein is a blood-brain barrier efflux transporter involved in the c...
m olpharm.aspetjournals.org D ow nloaded from 2 ATP-binding cassette transporters such as P-glycopro...
P-glycoprotein (P-gp) is an ATP-dependent efflux transporter located at the blood–brain barrier (BB...
Purpose: P-glycoprotein (Pgp) is an efflux transporter involved in transport of several compounds ac...
Abstract: The blood-brain barrier (BBB) impedes the influx of intravascular compounds from the blood...
Background: P-glycoprotein is a blood-brain barrier efflux transporter involved in the clearance of ...
Full list of author information is available at the end of the articleBackground Alzheimer’s disease...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Protection of the brain is strengthened by active transport and ABC transporters. P-glycoprotein (P-...
<p>One characteristic of Alzheimer’s disease (AD) is excessive accumulation of amyloid-β (Aβ) in the...
The accumulation of amyloid-b (Ab) peptides is a key histopathological feature of the Alzheimer's b...
Full list of author information is available at the end of the articleResults: PAPP-A was elevated i...
Amyloid precursor protein (APP) has been modified by β and γ-secretase that cause amy-loid deposits ...